The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Personalized risk assessment of new onset depression in long-term cancer survivors.
 
Melissa Taylor
No Relationships to Disclose
 
Sarah J. Westvold
No Relationships to Disclose
 
Jessica B. Long
No Relationships to Disclose
 
Terry Hyslop
Research Funding - Pfizer
 
Shi-Yi Wang
No Relationships to Disclose
 
Michael Cecchini
Stock and Other Ownership Interests - Parthenon Therapeutics
Honoraria - Agenus; AstraZeneca; Bayer; Daiichi Sankyo/Astra Zeneca; DAVA Pharmaceuticals; Elevation Oncology; Incendia Therapeutics; Loxo/Lilly; Macrogenics; Regeneron; Seagen; Taiho Oncology
 
Michael Leapman
No Relationships to Disclose
 
Ira Leeds
No Relationships to Disclose
 
Maryam B. Lustberg
Honoraria - Novartis
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Lilly; Novartis; Osmol Therapeutics; Pfizer; Seagen
Speakers' Bureau - Lilly
Other Relationship - Cynosure/Hologic
 
Lisa P. Spees
Research Funding - AstraZeneca/Merck
 
Stephanie B. Wheeler
Research Funding - AstraZeneca (Inst); Pfizer (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Cary Philip Gross
Research Funding - AstraZeneca (Inst); Genentech; Johnson & Johnson (Inst)
 
Kevin C. Oeffinger
No Relationships to Disclose
 
Michaela Ann Dinan
Research Funding - AstraZeneca (Inst); Janssen (I)